Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01358617 · ClinicalTrials.gov registry record
Prognostic Biomarkers in Tumor Tissue Samples From Young Patients With Neuroblastoma
A clinical trial, sponsored by Children's Oncology Group.
- Completed
- Registry status
- 90
- Enrollment target
NCT01358617 is a clinical trial that has completed, run by Children's Oncology Group. The registered enrollment target is 90 participants.
The verdict
NCT01358617 has completed, sponsored by Children's Oncology Group.
- COMPLETED
- Registry status
- 90 participants
- Enrollment target
Study Summary
This research study is studying biomarkers in tumor tissue samples from young patients with neuroblastoma. Studying samples of tissue from patients with cancer in the laboratory may help doctors identify biomarkers and learn more about biomarkers related to cancer
Interventions
- OTHER diagnostic laboratory biomarker analysis
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 90 participants |
| Start Date | 2011-05 |
| Est. Completion | 2011-08 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01358617
The ClinicalTrials.gov registry entry for NCT01358617 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 90 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Children's Oncology Group, which has 342 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which diagnostic laboratory biomarker analysis is the first listed.
NCT01358617 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01358617 about?
NCT01358617 is a clinical study titled "Prognostic Biomarkers in Tumor Tissue Samples From Young Patients With Neuroblastoma". This research study is studying biomarkers in tumor tissue samples from young patients with neuroblastoma. Studying samples of tissue from patients with cancer in the laboratory may help doctors identify biomarkers and learn more about biomarkers related to cancer
What is the current status of trial NCT01358617?
This trial is currently completed. The enrollment target is 90 participants. The study started on 2011-05. Estimated completion is 2011-08.
What interventions are being tested in trial NCT01358617?
The interventions under investigation include: diagnostic laboratory biomarker analysis (OTHER).
Who is sponsoring clinical trial NCT01358617?
This trial is sponsored by Children's Oncology Group, which has 342 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.